← Back to Search

Behavioral Intervention

Sarcoidosis Patient Assessment and Resource Companion App for Sarcoidosis (SPARC Trial)

N/A
Waitlist Available
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a smartphone app designed to help sarcoidosis patients manage their stress, which may help reduce their fatigue.

Eligible Conditions
  • Sarcoidosis
  • Fatigue and Malaise
  • Fatigue

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Participants Who Complete the Study
Number of Participants Who Maintain Adherence to at Least Daily Daily Breathing Awareness Meditation Sessions
Proportion of Participants Recruited
+1 more
Secondary study objectives
Change in Sarcoidosis Associated Fatigue From Baseline to Month 6
Changes in Autonomous Motivation
Changes in Quality of Life
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SPARC GroupExperimental Treatment1 Intervention
Group II: Enhanced Standard Care Control GroupActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sarcoidosis Patient Assessment and Resource Companion App
2022
N/A
~50

Find a Location

Who is running the clinical trial?

National Institute for Biomedical Imaging and Bioengineering (NIBIB)NIH
93 Previous Clinical Trials
20,242 Total Patients Enrolled
Medical University of South CarolinaLead Sponsor
974 Previous Clinical Trials
7,399,357 Total Patients Enrolled
3 Trials studying Sarcoidosis
51 Patients Enrolled for Sarcoidosis
~13 spots leftby Dec 2025